Axos Financial vs Banco Bilbao Viscaya Argentaria SA ADR: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Axos Financial Inc (AX)

Q3 202614 Jul – 29 Sep 2026

▲3

Axos beats on loan growth, guides to steady expansion

Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.
The earnings beat and its cause are the core new fact of the period.
Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.
Forward guidance tells readers where future earnings are headed, not just the last quarter.
Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.
Deal accretion and better credit quality are new supports for the stock.
Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.
It is the one real negative in the period and keeps the picture fair.

August 202614 Jul – 29 Sep 2026

▲3

Axos beats on loan growth, guides to steady expansion

Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.
The earnings beat and its cause are the core new fact of the period.
Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.
Forward guidance tells readers where future earnings are headed, not just the last quarter.
Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.
Deal accretion and better credit quality are new supports for the stock.
Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.
It is the one real negative in the period and keeps the picture fair.

Latest14 Jul – 29 Sep 2026

▲3

Axos beats on loan growth, guides to steady expansion

Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.
The earnings beat and its cause are the core new fact of the period.
Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.
Forward guidance tells readers where future earnings are headed, not just the last quarter.
Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.
Deal accretion and better credit quality are new supports for the stock.
Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.
It is the one real negative in the period and keeps the picture fair.

Banco Bilbao Viscaya Argentaria SA ADR (BBVA)

Q3 202617 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.

July 202617 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.

Latest17 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.